Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Thrombocytopenia and DPYD[original query] |
---|
Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy. Neoplasma 2009 56 (4): 303-16. Kleibl Z, Fidlerova J, Kleiblova P, Kormunda S, Bilek M, Bouskova K, Sevcik J, Novotny |
Influence of DPYD*9A, DPYD*6 and GSTP1 ile105val Genetic Polymorphisms on Capecitabine and Oxaliplatin (CAPOX) Associated Toxicities in Colorectal Cancer (CRC) Patients. Asian Pacific journal of cancer prevention : APJCP 2019 Oct 20 (10): 3093-3100. Varma K Ashok, Jayanthi M, Dubashi Biswajit, Shewade D |
Genetic influence of DPYD*9A polymorphism on plasma levels of 5-fluorouracil and subsequent toxicity after oral administration of capecitabine in colorectal cancer patients of South Indian origin. Drug metabolism and personalized therapy 2020 9 35 (4): . Varma Ashok, Jayanthi Mathaiyan, Dubashi Biswajit, Shewade Deepak Gopal, Sundaram Raj |
DPYD c.1905?+?1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer. Genetic testing and molecular biomarkers 2021 4 25 (4): 276-283. Deligonul Adem, Aksoy Secil, Tezcan Gulcin, Tunca Berrin, Kanat Ozkan, Cubukcu Erdem, Yilmazlar Tuncay, Ozturk Ersin, Egeli Unal, Cecener Gulsah, Alemdar Adem, Evrensel Turkk |
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 2021 Jan . Vivaldi Caterina, Crucitta Stefania, Catanese Silvia, Cucchiara Federico, Arrigoni Elena, Pecora Irene, Rofi Eleonora, Fornaro Lorenzo, Salani Francesca, Massa Valentina, Vasile Enrico, Morganti Riccardo, Danesi Romano, Del Re Marz |
Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. Frontiers in pharmacology 2023 9 14 1257745. Angela Wu, Helen Anderson, Curtis Hughesman, Sean Young, Caroline Lohrisch, Colin J D Ross, Bruce C Carlet |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: